Johnson & Johnson

Based in New Brunswick, Johnson & Johnson is widely regarded as one of USA's flagship pharmaceuticals operators. Its scale, about 132k people, around $85B in turnover, translates into genuine strategic weight across North America.

Management's emphasis on operational discipline, tight working capital, focused capex, clearer ESG roadmaps, is increasingly visible in margin trajectory.

“Johnson & Johnson is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Governance upgrades and a more transparent disclosure cadence are gradually narrowing the historical valuation gap with global peers.